Cargando…

The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities

In this review, we will first briefly describe the diverse molecular mechanisms associated with PTEN loss of function in cancer. We will then proceed to discuss the molecular mechanisms linking PTEN loss to PI3K activation and demonstrate how these mechanisms suggest possible therapeutic approaches...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Hyeyoun, Cai, Zhenying, Roberts, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921025/ https://www.ncbi.nlm.nih.gov/pubmed/31703360 http://dx.doi.org/10.3390/biom9110713

Ejemplares similares

An Opportune Suggestion
Publicado: (1914)

Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss
por: Bastos, Débora C, et al.
Publicado: (2020)

PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases
por: Cai, Bangrong, et al.
Publicado: (2022)

The Tumor Microenvironment in SCC: Mechanisms and Therapeutic Opportunities
por: Amôr, Nádia Ghinelli, et al.
Publicado: (2021)

New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway
por: Alfieri, Roberta, et al.
Publicado: (2017)

TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors
por: Amin, Amit Dipak, et al.
Publicado: (2016)

Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
por: Canale, Matteo, et al.
Publicado: (2020)

Loss of cellular adhesion to matrix induces p53-independent expression of PTEN tumor suppressor
por: Wu, Ray-Chang, et al.
Publicado: (2002)

Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening
por: Marchese, Maria, et al.
Publicado: (2014)

Loss of nuclear PTEN in HCV-infected human hepatocytes
por: Bao, Wenjie, et al.
Publicado: (2014)

Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
por: Johnston, Sean B., et al.
Publicado: (2015)

Modeling of Tumor Progression in NSCLC and Intrinsic Resistance to TKI in Loss of PTEN Expression
por: Bidkhori, Gholamreza, et al.
Publicado: (2012)

Atg7 cooperates with Pten loss to drive prostate cancer tumor growth
por: Santanam, Urmila, et al.
Publicado: (2016)

The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
por: Neophytou, Christiana M., et al.
Publicado: (2021)

Editorial: Tumor adaptation to cellular stresses: mechanisms, biomarkers and therapeutic opportunities
por: Cortesi, Michela, et al.
Publicado: (2023)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten
por: Liang, Xiaohuan, et al.
Publicado: (2018)

PTEN loss correlates with T cell exclusion across human cancers
por: Lin, Ziying, et al.
Publicado: (2021)

Brain patterning perturbations following PTEN loss
por: Veleva-Rotse, Biliana O., et al.
Publicado: (2014)

Pten loss results in inappropriate excitatory connectivity
por: Skelton, Patrick D., et al.
Publicado: (2019)

Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease
por: Cai, Qiuyu, et al.
Publicado: (2021)

PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles
por: Geybels, Milan S., et al.
Publicado: (2017)

Effects of PTEN Loss and Activated KRAS Overexpression on Mechanical Properties of Breast Epithelial Cells
por: Linthicum, Will, et al.
Publicado: (2018)

Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities
por: Luo, Yusong, et al.
Publicado: (2022)

Genome-Wide Identification of Gene Loss Events Suggests Loss Relics as a Potential Source of Functional lncRNAs in Humans
por: Wen, Zheng-Yang, et al.
Publicado: (2023)

Molecular mechanisms underlying therapeutic potential of pericytes
por: Harrell, C. Randall, et al.
Publicado: (2018)

Suggestion or Suggestive Therapeutics in the Practice of Medicine
por: Kesner, G. T.
Publicado: (1906)

PTEN: Multiple Functions in Human Malignant Tumors
por: Milella, Michele, et al.
Publicado: (2015)

Relationship Between PTEN and Angiogenesis of Esophageal Squamous Cell Carcinoma and the Underlying Mechanism
por: Yang, Chenbo, et al.
Publicado: (2021)

Suggestive Therapeutics
Publicado: (1889)

Therapeutic Suggestion
por: Parks, W. B.
Publicado: (1898)

Therapeutic Suggestions
Publicado: (1905)

The Role of PTEN in Tumor Angiogenesis
por: Rodriguez, Stéphane, et al.
Publicado: (2012)

The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane
por: Jang, Hyunbum, et al.
Publicado: (2021)

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
por: Punnoose, Elizabeth A, et al.
Publicado: (2015)

Lack of evidence for germline WWP1 pathogenic variants in gastrointestinal polyposis and other phenotypes suggestive of PTEN-hamartoma-tumor syndrome
por: Gonzalez-Abuin, Noemi, et al.
Publicado: (2023)

Nongenomic Mechanisms of PTEN Regulation
por: Fata, Jimmie E., et al.
Publicado: (2012)

Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
por: Szegedi, Krisztián, et al.
Publicado: (2023)

High-expression of DJ-1 and Loss of PTEN Associated with Tumor Metastasis and Correlated with Poor Prognosis of Gastric Carcinoma
por: Li, Yin, et al.
Publicado: (2013)

Is PTEN loss associated with clinical outcome measures in human prostate cancer?
por: McCall, P, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8k8i2nb1qo43bpj3tinj2ipk3c